Karen E. Gascoigne

4.0k total citations · 1 hit paper
21 papers, 2.5k citations indexed

About

Karen E. Gascoigne is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Karen E. Gascoigne has authored 21 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Cell Biology and 4 papers in Oncology. Recurrent topics in Karen E. Gascoigne's work include Microtubule and mitosis dynamics (9 papers), Genomics and Chromatin Dynamics (8 papers) and Protein Degradation and Inhibitors (6 papers). Karen E. Gascoigne is often cited by papers focused on Microtubule and mitosis dynamics (9 papers), Genomics and Chromatin Dynamics (8 papers) and Protein Degradation and Inhibitors (6 papers). Karen E. Gascoigne collaborates with scholars based in United States, United Kingdom and France. Karen E. Gascoigne's co-authors include Stephen S. Taylor, Iain M. Cheeseman, K. Takeuchi, Tetsuya Hori, Aussie Suzuki, Tatsuo Fukagawa, Florencia Rago, Peter M. Haverty, Claire Crafter and Fiona Girdler and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Karen E. Gascoigne

19 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs

2008 655 citations Karen E. Gascoigne, Stephen S. Taylor Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen E. Gascoigne United States	17	2.1k	1.3k	664	422	202	21	2.5k
Libor Macůrek Czechia	29	2.2k 1.1×	1.3k 1.0×	885 1.3×	189 0.4×	286 1.4×	54	2.8k
Anthony Tighe United Kingdom	19	2.5k 1.2×	2.2k 1.7×	934 1.4×	381 0.9×	197 1.0×	27	3.0k
Matthias Hoffmann Germany	9	1.5k 0.7×	1.1k 0.9×	635 1.0×	141 0.3×	143 0.7×	11	2.0k
Aniek Janssen Netherlands	14	1.5k 0.7×	863 0.7×	409 0.6×	285 0.7×	298 1.5×	19	1.9k
Beth A.A. Weaver United States	6	2.0k 0.9×	1.7k 1.3×	812 1.2×	299 0.7×	471 2.3×	6	2.6k
Irene C. Waizenegger Austria	20	2.8k 1.3×	1.7k 1.3×	417 0.6×	924 2.2×	125 0.6×	31	3.4k
Alexis R. Barr United Kingdom	20	1.4k 0.7×	859 0.7×	631 1.0×	147 0.3×	304 1.5×	30	2.1k
Jeffrey Ecsedy United States	32	2.0k 1.0×	2.1k 1.6×	1.6k 2.5×	159 0.4×	361 1.8×	71	3.5k
Gordon K. Chan Canada	33	3.9k 1.8×	3.1k 2.4×	831 1.3×	745 1.8×	253 1.3×	53	4.4k
Gerben Vader Netherlands	17	1.9k 0.9×	1.4k 1.1×	529 0.8×	389 0.9×	108 0.5×	26	2.2k

Countries citing papers authored by Karen E. Gascoigne

Since Specialization

Citations

This map shows the geographic impact of Karen E. Gascoigne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen E. Gascoigne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen E. Gascoigne more than expected).

Fields of papers citing papers by Karen E. Gascoigne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen E. Gascoigne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen E. Gascoigne. The network helps show where Karen E. Gascoigne may publish in the future.

Co-authorship network of co-authors of Karen E. Gascoigne

This figure shows the co-authorship network connecting the top 25 collaborators of Karen E. Gascoigne. A scholar is included among the top collaborators of Karen E. Gascoigne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen E. Gascoigne. Karen E. Gascoigne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Raisner, Ryan, et al.. (2025). PAX8 Interacts with the SWI/SNF Complex at Enhancers to Drive Proliferation in Ovarian Cancer. Molecular Cancer Research. 23(5). 416–425.

Liu, Chad, Takamasa Kudo, Xin Ye, & Karen E. Gascoigne. (2023). Cell-to-cell variability in Myc dynamics drives transcriptional heterogeneity in cancer cells. Cell Reports. 42(4). 112401–112401. 12 indexed citations

Raisner, Ryan, et al.. (2020). Super-enhancer acquisition drives oncogene expression in triple negative breast cancer. PLoS ONE. 15(6). e0235343–e0235343. 21 indexed citations

Nagata, Denise E. de Almeida, Eugene Y. Chiang, Suchit Jhunjhunwala, et al.. (2019). Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Cell Reports. 27(1). 269–281.e4. 54 indexed citations

Fortin, Jean‐Philippe, Jenille Tan, Karen E. Gascoigne, et al.. (2019). Multiple-gene targeting and mismatch tolerance can confound analysis of genome-wide pooled CRISPR screens. Genome biology. 20(1). 21–21. 27 indexed citations

Raisner, Ryan, Samir Kharbanda, Lingyan Jin, et al.. (2018). Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. Cell Reports. 24(7). 1722–1729. 223 indexed citations

Jin, Lingyan, Emily Chan, Ehud Segal, et al.. (2017). Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer. Cancer Research. 77(20). 5564–5575. 105 indexed citations

Conery, Andrew R., Richard C. Centore, Adrianne Neiss, et al.. (2016). Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. eLife. 5. 84 indexed citations

Asundi, Jyoti, Lisa Crocker, Jarrod R. Tremayne, et al.. (2015). An Antibody–Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies. Clinical Cancer Research. 21(14). 3252–3262. 28 indexed citations

10.

Rago, Florencia, Karen E. Gascoigne, & Iain M. Cheeseman. (2015). Distinct Organization and Regulation of the Outer Kinetochore KMN Network Downstream of CENP-C and CENP-T. Current Biology. 25(5). 671–677. 108 indexed citations

11.

Gascoigne, Karen E. & Iain M. Cheeseman. (2013). Induced dicentric chromosome formation promotes genomic rearrangements and tumorigenesis. Chromosome Research. 21(4). 407–418. 54 indexed citations

12.

Gascoigne, Karen E. & Iain M. Cheeseman. (2013). CDK-dependent phosphorylation and nuclear exclusion coordinately control kinetochore assembly state. The Journal of Cell Biology. 201(1). 23–32. 74 indexed citations

13.

Nishino, Tatsuya, K. Takeuchi, Karen E. Gascoigne, et al.. (2012). CENP-T-W-S-X Forms a Unique Centromeric Chromatin Structure with a Histone-like Fold. Cell. 148(3). 487–501. 191 indexed citations

14.

Gascoigne, Karen E., K. Takeuchi, Aussie Suzuki, et al.. (2011). Induced Ectopic Kinetochore Assembly Bypasses the Requirement for CENP-A Nucleosomes. Cell. 145(3). 410–422. 268 indexed citations

15.

Gascoigne, Karen E. & Iain M. Cheeseman. (2010). Kinetochore assembly: if you build it, they will come. Current Opinion in Cell Biology. 23(1). 102–108. 48 indexed citations

16.

Gascoigne, Karen E. & Stephen S. Taylor. (2009). How do anti-mitotic drugs kill cancer cells?. Journal of Cell Science. 122(15). 2579–2585. 290 indexed citations

17.

Gascoigne, Karen E. & Stephen S. Taylor. (2008). Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs. Cancer Cell. 14(2). 111–122. 655 indexed citations breakdown →

18.

Girdler, Fiona, Karen E. Gascoigne, Patrick A. Eyers, et al.. (2006). Validating Aurora B as an anti-cancer drug target. Journal of Cell Science. 119(17). 3664–3675. 228 indexed citations

19.

Offman, Judith, Karen E. Gascoigne, Peter Macpherson, et al.. (2005). Repeated Sequences in CASPASE-5 and FANCD2 but not NF1 Are Targets for Mutation in Microsatellite-Unstable Acute Leukemia/Myelodysplastic Syndrome. Molecular Cancer Research. 3(5). 251–260. 16 indexed citations

20.

Kasza, Aneta, Amanda O’Donnell, Karen E. Gascoigne, et al.. (2004). The ETS Domain Transcription Factor Elk-1 Regulates the Expression of Its Partner Protein, SRF. Journal of Biological Chemistry. 280(2). 1149–1155. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact